Titan attributed the lower earnings to higher selling, general and administrative costs, which reflected costs associated with the acquisitions last year of Titan Europe P.L.C. and Planet Group. Income from operations fell 18.4 percent to $47.9 million ...

Ryanair Holdings plc CEO Michael O'Leary has been winding up rivals for years with talk of entering the transatlantic market, but the chat has been just that until the low-fare titan recently unveiled plans to fly determined sun-seekers from ...

... Q1 14-May ES 7:00 TECNICAS REUNIDAS SA Q1 14-May IT TERNA RETE ELETTRICA NAZIONALE SPA Q1 14-May GR AMC TITAN CEMENT COMPANY SA Q1 14-May DE TECHNOTRANS AG Q1 14-May DE UMS UNITED MEDICAL SYS INTERNATIO ... NORDEX SE Q1 15-May GB NEW EUROPE ...

LN), a European exploration company, Tuesday posted a narrowed pretax loss for the first three months of 2013, and said that the Cyprus banking crisis had no notable impact on the company.

Western European Corp Meetings European hits & misses Major European Co.'s earnings Monthly S&P 500 earnings Weekly non-S&P 500 earnings Day ahead S&P 500 earnings Weekly conference call/webcast Weekly meetings Global Company News ...

Western European Corp Meetings European hits & misses Major European Co.'s earnings Monthly S&P 500 earnings Weekly non-S&P 500 earnings Day ahead S&P 500 earnings Weekly conference call/webcast Weekly meetings Global Company News ...

Amarin Corporation plc (NASDAQ:AMRN), too, is a company whose patents are day-by-day being tallied by at investors at home, given the continued uncertainty surrounding Vascepa's New Chemical Entity (NCE) status.

Commodities titan Glencore International PLC (GLEN.LN) and Anglo Swiss miner Xstrata PLC (XTA.LN) announced 15 months ago plans to merge their operations into a globally diversified natural resources company with a market capitalization of $66 billion ...

Recent reports have suggested Verizon is patching together a $100 billion bid for Vodafone PLC's 45 percent stake in the venture, firing up speculation that the pair could be nearing a deal after Verizon's long-standing interest in doing so.

Avanir Pharmaceuticals (AVNR) jumped 2.81% on Friday after a European regulator looked favorably upon its product Neudexta to treat sudden uncontrollable laughing or crying.